Pradalex is an innovative third generation fluoroquinolone antibiotic for the treatment of bovine respiratory disease (BRD), only after consideration of other non-fluoroquinolones therapeutic options. Pradofloxacin, the active ingredient in Pradalex, uniquely features two modes of action. Concentration dependent antibiotic with a dual mode of action that kills bacteria before they can replicate Demonstrated quick elimination from the body, resulting in a shorter withdrawal period. Convenient, single dose, low-volume antibiotic with excellent syringeability Indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis only after consideration of other non-fluoroquinolones therapeutic options
